TipRanks
Go Ultimate55% OFF

ETFs with Neuphoria Therapeutics (NEUP) Exposure

The following ETFs maintain exposure to Neuphoria Therapeutics (NEUP). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.

3 ETFs Hold Neuphoria Therapeutics (NEUP)

ETFs holding NEUP
SymbolETF NameAUMExpense Ratio% Weight in ETFMarket Value% Weight in NEUP
PSILAdvisorShares Psychedelics ETF$46.62M1.00%1.91%$889.40K5.37%
VXFVanguard Extended Market ETF$30.86B0.05%<0.01%$225.41K1.17%
VTIVanguard Total Stock Market ETF$701.51B0.03%<0.01%$392.21K2.04%
Find ETFs with the TipRanks ETF screener

Popular ETFs

Popular ETFs
CompanyPrice & ChangeFollow
SPYSPDR S&P 500 ETF Trust―
QQQInvesco QQQ Trust―
DIASPDR Dow Jones Industrial Average ETF Trust―
IWMiShares Russell 2000 ETF―
VOOVanguard S&P 500 ETF―

NEUP ETF Exposure FAQ

What ETFs hold Neuphoria Therapeutics stock?
Neuphoria Therapeutics (NEUP) is currently held by 3 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to NEUP include AdvisorShares (PSIL), Vanguard (VTI) and Vanguard (VXF).
Which ETF has the largest exposure to NEUP?
The ETF with the largest exposure to NEUP is AdvisorShares (PSIL), with approximately $889.40K in market value exposure.
How much NEUP stock is held by ETFs?
ETFs currently hold approximately $1.51M worth of Neuphoria Therapeutics (NEUP) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.